Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine in Taiwanese Patients With MDS
NCT00744757Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Aug 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), acute myeloid leukemia (AML), sponsored by Johnson & Johnson. Started Aug 2008; status: completed.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)chronic myelomonocytic leukemia (CMML)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00744757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00744757.